Daniel Foitl, MD
Dermatology · New York, NYNPI 1861499147
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,243 of the $8,418 with a category attached, or 86.0%. It is spread thinly across 31 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,193 and has fallen 61.4% since, to $846 in 2025.
Across 370 payments — averaging $22.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Galderma Laboratories, L.p.$828
- Johnson & Johnson$772
- LEO Pharma Inc.$746
- Sanofi$515
- Pfizer$480
- plus $3K from 25 others
What the payments were for
- Speaking & faculty fees$84310%
- Food & beverage$7,24386%
- Education$3324%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 65 | $1,967 |
| Galderma Laboratories, L.p. | 32 | $828 |
| Johnson & Johnson | 25 | $772 |
| LEO Pharma Inc. | 54 | $746 |
| Sanofi | 21 | $515 |
| Pfizer | 24 | $480 |
| Sun Pharmaceutical Industries Inc. | 20 | $440 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 22 | $336 |
| Incyte Corporation | 10 | $246 |
| Lilly USA, LLC | 10 | $225 |
| E.r. Squibb & Sons, L.L.C. | 8 | $202 |
| UCB, Inc. | 7 | $196 |
| Novartis | 7 | $175 |
| Almirall LLC | 7 | $154 |
| Mayne Pharma Commercial LLC | 6 | $143 |
| Bristol Myers Squibb | 15 | $140 |
| Regeneron Healthcare Solutions, Inc. | 3 | $126 |
| Amgen | 4 | $111 |
| Sandoz | 5 | $95 |
| Dermira, Inc. | 4 | $93 |
| VYNE Pharmaceuticals Inc. | 3 | $82 |
| Strata Skin Sciences, Inc. | 5 | $71 |
| Taro Pharmaceuticals USA, Inc. | 3 | $46 |
| Dermavant Sciences, Inc. | 2 | $46 |
| Mission Pharmacal Company | 2 | $33 |
| Blueprint Medicines Corporation | 1 | $29 |
| Encore Dermatology Inc. | 1 | $29 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $25 |
| DUSA Pharmaceuticals, Inc. | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SOOLANTRA$282
- EPIDUO FORTE$282
- ORACEA$170
- Winlevi$125
- Skyrizi$122
How this compares
$8,418 in reported general payments places this provider in the 70th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 40 | $48,393 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 12 | $14,250 |
| Minoxidil | 325 | $5,362 |
| Halobetasol Propionate | 102 | $4,696 |
| ValacyclovirValacyclovir Hcl | 71 | $4,501 |
| Mometasone Furoate | 131 | $2,766 |
| Clobetasol Propionate | 36 | $1,452 |
| Finasteride | 86 | $1,401 |
| Ketoconazole | 66 | $1,373 |
| Doxycycline Hyclate | 40 | $1,291 |
| Fluorouracil | 22 | $1,193 |
| Tretinoin | 17 | $1,180 |
| Triamcinolone Acetonide | 87 | $1,029 |
| Dutasteride | 23 | $883 |
| Diclofenac Sodium | 12 | $728 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.